Showing results (31-40 of 93) with videos related to

Sort By:
Pageof 10
Diabetologia|May 1, 1995
Cholesterol-lowering therapy may retard the progression of diabetic nephropathyK S Lam, I K Cheng, E D Janus, et al.
The New Zealand Medical Journal|February 9, 1983
Hyperbetalipoproteinaemia and hyperalphalipoproteinaemia in a single familyE R Nye, D R Harding, W S Hancock, et al.
Diabetes|June 1, 1991
Increased plasma apolipoprotein(a) levels in IDDM patients with microalbuminuriaA J Jenkins, J S Steele, E D Janus, et al.
FEBS Letters|November 1, 1982
In vitro synthesis of M and Z forms of human alpha 1-antitrypsinD M Errington, I C Bathurst, E D Janus, et al.
The New Zealand Medical Journal|November 12, 1975
Alpha-1-antitrypsin variants in New ZealandE D Janus, P R Joyce, J M Sheat, et al.
Atherosclerosis|February 28, 1997
LDL subfractions in acromegaly: relation to growth hormone and insulin-like growth factor-IK C Tan, S W Shiu, E D Janus, et al.
Pathology|August 1, 1996
Kinetic characterisation of alpha-1-antitrypsin F as an inhibitor of human neutrophil elastaseL Cook, J G Burdon, S Brenton, et al.
European Journal of Clinical Investigation|April 1, 1980
Kinetic bases of the primary hyperlipidaemias: studies of apolipoprotein B turnover in genetically defined subjectsE D Janus, A M Nicoll, P R Turner, et al.
The Journal of Clinical Investigation|August 1, 1987
Apolipoprotein E2-Christchurch (136 Arg----Ser). New variant of human apolipoprotein E in a patient with type III hyperlipoproteinemiaM R Wardell, S O Brennan, E D Janus, et al.
Atherosclerosis|April 27, 1999
The relationship between fibrinogen and other coronary heart disease risk factors in a Chinese populationT H Lam, L J Liu, E D Janus, et al.
Pageof 10